LAMEA Point of Care Molecular Diagnostics Market Size, Share & Industry Trends Analysis Report By Product & Service (Assays & Kits, Instruments & Analyzers and Software & Services), By End User, By Technology, By Application, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Point of Care Molecular Diagnostics Market would witness market growth of 13.6% CAGR during the forecast period (2023-2030).

The status of medical services, particularly STD treatment, is being improved across this area via collaboration between several governments and significant healthcare institutions. To improve the regional situation of STD cases 2029, governments have developed strategies, including STD prevention, detection, and early diagnosis. Therefore, individuals without formal laboratory training may also do POC testing. Point-of-care testing can potentially change the prevention and management of STIs by stopping transmission and averting the consequences of untreated infections by allowing quick detection and early treatment of infections.

One of the main factors driving this market is the rising incidence of cardiovascular illnesses, diabetes, cancer, and infectious disorders. Factors including the regional increase in smoking, bad diets, and rising obesity rates cause the increased prevalence of cardiovascular illnesses worldwide. The need for POC MDx tests has grown due to unmet medical requirements relating to cardiovascular conditions and the development in patient knowledge of different breakthroughs in disease diagnostics.

In the African continent, the frequency of STDs or STIs is on the rise, causing several health issues and major difficulties. Sub-Saharan Africa has the most significant yearly STD cases compared to other areas. The World Health Organization estimates that each year, Africa experiences 3.5 million instances of syphilis, 16 million cases of gonorrhea, 15 million cases of chlamydial disease, and 30 million cases of trichomoniasis. As a result, the point-of-care molecular testing market in LAMEA is expanding due to the increasing use of POC testing for STDs.

The Brazil market dominated the LAMEA Point of Care Molecular Diagnostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $70.9 million by 2030. The Argentina market is poised to grow at a CAGR of 14.2% during (2023 - 2030). Additionally, The UAE market would display a CAGR of 13.3% during (2023 - 2030).

Based on Product & Service, the market is segmented into Assays & Kits, Instruments & Analyzers and Software & Services. Based on End User, the market is segmented into Physicians Offices, Hospitals & ICUs, Research Institutes and Others. Based on by Technology, the market is segmented into RT-PCR, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others. Based on Application, the market is segmented into Respiratory Diseases, Hospital-acquired Infections, Sexually Transmitted Diseases, Cancer, Hepatitis, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Point of Care Molecular Diagnostics Market is Projected to reach USD 4.1 Billion by 2030, at a CAGR of 10.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd., Qiagen N.V., Danaher Corporation, Bio-Rad Laboratories, Inc., BioMerieux S.A., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and Nova Biomedical Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Product & Service

• Assays & Kits
• Instruments & Analyzers
• Software & Services Surveillance & Monitoring

By End User

• Physicians Offices
• Hospitals & ICUs
• Research Institutes
• Others

By Technology

• RT-PCR
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

By Application

• Respiratory Diseases
• Hospital-acquired Infections
• Sexually Transmitted Diseases
• Cancer
• Hepatitis
• Gastrointestinal Disorders
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Bayer AG
• F.Hoffmann-La Roche Ltd.
• Qiagen N.V.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• BioMerieux S.A.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Nova Biomedical Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Point of Care Molecular Diagnostics Market, by Product & Service
1.4.2 LAMEA Point of Care Molecular Diagnostics Market, by End User
1.4.3 LAMEA Point of Care Molecular Diagnostics Market, by Technology
1.4.4 LAMEA Point of Care Molecular Diagnostics Market, by Application
1.4.5 LAMEA Point of Care Molecular Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. LAMEA Point of Care Molecular Diagnostics Market by Product & Service
4.1 LAMEA Assays & Kits Market by Country
4.2 LAMEA Instruments & Analyzers Market by Country
4.3 LAMEA Software & Services Market by Country

Chapter 5. LAMEA Point of Care Molecular Diagnostics Market by End User
5.1 LAMEA Physicians Offices Market by Country
5.2 LAMEA Hospitals & ICUs Market by Country
5.3 LAMEA Research Institutes Market by Country
5.4 LAMEA Others Market by Country

Chapter 6. LAMEA Point of Care Molecular Diagnostics Market by Technology
6.1 LAMEA RT-PCR Market by Country
6.2 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Point of Care Molecular Diagnostics Market by Application
7.1 LAMEA Respiratory Diseases Market by Country
7.2 LAMEA Hospital-acquired Infections Market by Country
7.3 LAMEA Sexually Transmitted Diseases Market by Country
7.4 LAMEA Cancer Market by Country
7.5 LAMEA Hepatitis Market by Country
7.6 LAMEA Gastrointestinal Disorders Market by Country
7.7 LAMEA Others Market by Country

Chapter 8. LAMEA Point of Care Molecular Diagnostics Market by Country
8.1 Brazil Point of Care Molecular Diagnostics Market
8.1.1 Brazil Point of Care Molecular Diagnostics Market by Product & Service
8.1.2 Brazil Point of Care Molecular Diagnostics Market by End User
8.1.3 Brazil Point of Care Molecular Diagnostics Market by Technology
8.1.4 Brazil Point of Care Molecular Diagnostics Market by Application
8.2 Argentina Point of Care Molecular Diagnostics Market
8.2.1 Argentina Point of Care Molecular Diagnostics Market by Product & Service
8.2.2 Argentina Point of Care Molecular Diagnostics Market by End User
8.2.3 Argentina Point of Care Molecular Diagnostics Market by Technology
8.2.4 Argentina Point of Care Molecular Diagnostics Market by Application
8.3 UAE Point of Care Molecular Diagnostics Market
8.3.1 UAE Point of Care Molecular Diagnostics Market by Product & Service
8.3.2 UAE Point of Care Molecular Diagnostics Market by End User
8.3.3 UAE Point of Care Molecular Diagnostics Market by Technology
8.3.4 UAE Point of Care Molecular Diagnostics Market by Application
8.4 Saudi Arabia Point of Care Molecular Diagnostics Market
8.4.1 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service
8.4.2 Saudi Arabia Point of Care Molecular Diagnostics Market by End User
8.4.3 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology
8.4.4 Saudi Arabia Point of Care Molecular Diagnostics Market by Application
8.5 South Africa Point of Care Molecular Diagnostics Market
8.5.1 South Africa Point of Care Molecular Diagnostics Market by Product & Service
8.5.2 South Africa Point of Care Molecular Diagnostics Market by End User
8.5.3 South Africa Point of Care Molecular Diagnostics Market by Technology
8.5.4 South Africa Point of Care Molecular Diagnostics Market by Application
8.6 Nigeria Point of Care Molecular Diagnostics Market
8.6.1 Nigeria Point of Care Molecular Diagnostics Market by Product & Service
8.6.2 Nigeria Point of Care Molecular Diagnostics Market by End User
8.6.3 Nigeria Point of Care Molecular Diagnostics Market by Technology
8.6.4 Nigeria Point of Care Molecular Diagnostics Market by Application
8.7 Rest of LAMEA Point of Care Molecular Diagnostics Market
8.7.1 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service
8.7.2 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User
8.7.3 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology
8.7.4 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
9.10.1 Company Overview

TABLE 1 LAMEA Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Point of Care Molecular Diagnostics Market
TABLE 4 Product Launches And Product Expansions- Point of Care Molecular Diagnostics Market
TABLE 5 Acquisition and Mergers- Point of Care Molecular Diagnostics Market
TABLE 6 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 7 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 8 LAMEA Assays & Kits Market by Country, 2019 - 2022, USD Million
TABLE 9 LAMEA Assays & Kits Market by Country, 2023 - 2030, USD Million
TABLE 10 LAMEA Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 11 LAMEA Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 12 LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 13 LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 14 LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 15 LAMEA Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 16 LAMEA Physicians Offices Market by Country, 2019 - 2022, USD Million
TABLE 17 LAMEA Physicians Offices Market by Country, 2023 - 2030, USD Million
TABLE 18 LAMEA Hospitals & ICUs Market by Country, 2019 - 2022, USD Million
TABLE 19 LAMEA Hospitals & ICUs Market by Country, 2023 - 2030, USD Million
TABLE 20 LAMEA Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 21 LAMEA Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 22 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 23 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 24 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 25 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 26 LAMEA RT-PCR Market by Country, 2019 - 2022, USD Million
TABLE 27 LAMEA RT-PCR Market by Country, 2023 - 2030, USD Million
TABLE 28 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2019 - 2022, USD Million
TABLE 29 LAMEA Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country, 2023 - 2030, USD Million
TABLE 30 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 31 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 32 LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 33 LAMEA Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 34 LAMEA Respiratory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 35 LAMEA Respiratory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 36 LAMEA Hospital-acquired Infections Market by Country, 2019 - 2022, USD Million
TABLE 37 LAMEA Hospital-acquired Infections Market by Country, 2023 - 2030, USD Million
TABLE 38 LAMEA Sexually Transmitted Diseases Market by Country, 2019 - 2022, USD Million
TABLE 39 LAMEA Sexually Transmitted Diseases Market by Country, 2023 - 2030, USD Million
TABLE 40 LAMEA Cancer Market by Country, 2019 - 2022, USD Million
TABLE 41 LAMEA Cancer Market by Country, 2023 - 2030, USD Million
TABLE 42 LAMEA Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 43 LAMEA Hepatitis Market by Country, 2023 - 2030, USD Million
TABLE 44 LAMEA Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Million
TABLE 45 LAMEA Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Million
TABLE 46 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 47 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 48 LAMEA Point of Care Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 49 LAMEA Point of Care Molecular Diagnostics Market by Country, 2023 - 2030, USD Million
TABLE 50 Brazil Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 51 Brazil Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 52 Brazil Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 53 Brazil Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 54 Brazil Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 55 Brazil Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 56 Brazil Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 57 Brazil Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 58 Brazil Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 59 Brazil Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 60 Argentina Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 61 Argentina Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 62 Argentina Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 63 Argentina Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 64 Argentina Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 65 Argentina Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 66 Argentina Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 67 Argentina Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 68 Argentina Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 69 Argentina Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 70 UAE Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 71 UAE Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 72 UAE Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 73 UAE Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 74 UAE Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 75 UAE Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 76 UAE Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 77 UAE Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 78 UAE Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 79 UAE Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 80 Saudi Arabia Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 81 Saudi Arabia Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 82 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 83 Saudi Arabia Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 84 Saudi Arabia Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 85 Saudi Arabia Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 86 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 87 Saudi Arabia Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 88 Saudi Arabia Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 89 Saudi Arabia Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 90 South Africa Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 91 South Africa Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 92 South Africa Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 93 South Africa Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 94 South Africa Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 95 South Africa Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 96 South Africa Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 97 South Africa Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 98 South Africa Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 99 South Africa Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 100 Nigeria Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 101 Nigeria Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 102 Nigeria Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 103 Nigeria Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 104 Nigeria Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 105 Nigeria Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 106 Nigeria Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 107 Nigeria Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 108 Nigeria Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 109 Nigeria Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 110 Rest of LAMEA Point of Care Molecular Diagnostics Market, 2019 - 2022, USD Million
TABLE 111 Rest of LAMEA Point of Care Molecular Diagnostics Market, 2023 - 2030, USD Million
TABLE 112 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2022, USD Million
TABLE 113 Rest of LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2023 - 2030, USD Million
TABLE 114 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2022, USD Million
TABLE 115 Rest of LAMEA Point of Care Molecular Diagnostics Market by End User, 2023 - 2030, USD Million
TABLE 116 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2022, USD Million
TABLE 117 Rest of LAMEA Point of Care Molecular Diagnostics Market by Technology, 2023 - 2030, USD Million
TABLE 118 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2022, USD Million
TABLE 119 Rest of LAMEA Point of Care Molecular Diagnostics Market by Application, 2023 - 2030, USD Million
TABLE 120 Key Information - Abbott Laboratories
TABLE 121 Key Information - Bayer AG
TABLE 122 Key Information - Thermo Fisher Scientific, Inc.
TABLE 123 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
TABLE 124 Key information - BioMerieux S.A.
TABLE 125 Key Information - Qiagen N.V.
TABLE 126 Key Information - Danaher Corporation
TABLE 127 Key Information - Bio-Rad Laboratories, Inc.
TABLE 128 key Information - Agilent Technologies, Inc.
TABLE 129 key information - Nova Biomedical Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 LAMEA Point of Care Molecular Diagnostics Market share by Product & Service, 2022
FIG 5 LAMEA Point of Care Molecular Diagnostics Market share by Product & Service, 2030
FIG 6 LAMEA Point of Care Molecular Diagnostics Market by Product & Service, 2019 - 2030, USD Million
FIG 7 LAMEA Point of Care Molecular Diagnostics Market share by End User, 2022
FIG 8 LAMEA Point of Care Molecular Diagnostics Market share by End User, 2030
FIG 9 LAMEA Point of Care Molecular Diagnostics Market by End User, 2019 - 2030, USD Million
FIG 10 LAMEA Point of Care Molecular Diagnostics Market share by Technology, 2022
FIG 11 LAMEA Point of Care Molecular Diagnostics Market share by Technology, 2030
FIG 12 LAMEA Point of Care Molecular Diagnostics Market by Technology, 2019 - 2030, USD Million
FIG 13 LAMEA Point of Care Molecular Diagnostics Market share by Application, 2022
FIG 14 LAMEA Point of Care Molecular Diagnostics Market share by Application, 2030
FIG 15 LAMEA Point of Care Molecular Diagnostics Market by Application, 2019 - 2030, USD Million
FIG 16 LAMEA Point of Care Molecular Diagnostics Market share by Country, 2022
FIG 17 LAMEA Point of Care Molecular Diagnostics Market share by Country, 2030
FIG 18 LAMEA Point of Care Molecular Diagnostics Market by Country, 2019 - 2030, USD Million
FIG 19 Swot Analysis: Abbott Laboratories
FIG 20 Swot Analysis: Bayer AG
FIG 21 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 22 Recent strategies and developments: F. Hoffmann-La Roche Ltd.